NEW YORK, NY / ACCESSWIRE / February 11, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court.
/PRNewswire/ RM LAW, P.C. announces that a class action lawsuit has been filed on behalf of all persons or entities that purchased iRhythm Technologies, Inc..
On January 29, 2021, Medicare Administrative Contractor Novitas Solutions published reimbursement rates for extended external electrocardiography devices, including iRhythm's wearable heart rate monitors, under the U.S. Centers for Medicare and Medicaid Services 2021 Medicare Physician Fee Schedule. On this news, iRhythm's stock price fell $82.58.
News | ECG | February 02, 2021
Cardiac Insight Speaks Out Against Medicare Decision to Slash Reimbursement Rates and Limit Access to New ECG Technologies
There has been an increasing trend in cardiology to use longer term remote monitoring wearable ECG tracking devices. This is an example of of the Cardiac Insight Cardea Solo adhesive patch device.
February 2, 2021 Cardiac Insight, Inc. a healthcare company specializing in wearable cardiac sensors and automated electrocardiogram (ECG) analysis, said a recent Medicare reimbursement rate reduction for long-term electrocardiogram (ECG) monitoring is a big set back for patient care.
The rates published by Medicare Administrative Contractor (MAC) Novitas Solutions for CPT codes 93241, 93243, 93245, and 93247 showed up to a 74% reduction in physician reimbursements, Cardiac Insight said.